Company Overview of Preventec, Inc.
Preventec, Inc. engages in the development of genetic modified rice in Japan. The company also produces proteins for medical uses, food industry, and research reagents. Its products include cytokine medicines for oral administration; antibody medicines that modulate intestinal immune systems; and serum proteins. The company was founded in 2006 and is based in Ibaraki, Japan.
1-2, Owashi Tsukuba
Founded in 2006
81 2 9838 6261
81 2 9838 6261
Key Executives for Preventec, Inc.
Similar Private Companies By Industry
|Amano Enzyme Inc.||Asia|
|ArBlast Co., Ltd.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Preventec, Inc., please visit www.preventec-inc.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.